BioLight Life (Israel) Valuation

BOLT -- Israel Stock  

ILS 1,367  7.00  0.51%

BioLight Life Sciences shows prevailing Real Value of S1089.45 per share. The current price of the firm is S1367.0. At this time the firm appears to be overvalued. Macroaxis approximates value of BioLight Life Sciences from analyzing the firm fundamentals such as Price to Earning of 84.04X, Current Valuation of 18.35M and Return On Equity of 115.52% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
Horizon     30 Days    Login   to change
BioLight Life Sciences Ltd is rated below average in price to sales category among related companies. It is rated below average in price to book category among related companies fabricating about  5.26  of Price to Book per Price to Sales.

Current Market Valuation

BioLight Life Sciences Valuation Boundaries

Overvalued
March 21, 2019
1,367
Market Value
1,089
Real Value
Target Odds
Odds Odds
1,504
Upside
BioLight Life is not too risky asset. Calculation of real value of BioLight Life Sciences is based on 2 months time horizon. Increasing BioLight Life Sciences time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Check also Trending Equities. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Search macroaxis.com